High mobility group protein-1 (HMG-1) is a unique activator of p53

被引:282
作者
Jayaraman, L
Moorthy, NC
Murthy, KGK
Manley, JL
Bustin, M
Prives, C [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] NIH, Bethesda, MD 20892 USA
关键词
p53; protein; HMG-1; DNA-binding activation; transcription;
D O I
10.1101/gad.12.4.462
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The binding of p53 protein to DNA is stimulated by its interaction with covalent as well as noncovalent modifiers. We report the identification of a factor from HeLa nuclear extracts that activates p53 DNA binding. This factor was purified to homogeneity and identified as the high mobility group protein, HMG-1. HMG-1 belongs to a family of highly conserved chromatin-associated nucleoproteins that bend DNA and facilitate the binding of various transcription factors to their cognate DNA sequences. We demonstrate that recombinant His-tagged HMG-1 enhances p53 DNA binding in vitro and also that HMG-1 and p53 can interact directly in vitro. Unexpectedly, HMG-1 also stimulates DNA binding by p53 Delta 30, a carboxy terminally deleted form of the protein that is considered to be constitutively active, suggesting that HMG-1 stimulates p53 by a mechanism that is distinct from other known activators of p53. Finally, using transient transfection assays we show that HMG-1 can increase p53 and p53 Delta 30-mediated transactivation in vivo. HMG-1 promotes the assembly of higher order p53 nucleoprotein structures, and these data, along with the fact that HMG-1 is capable of bending DNA, suggest that HMG-1 may activate p53 DNA binding by a novel mechanism involving a structural change in the target DNA.
引用
收藏
页码:462 / 472
页数:11
相关论文
共 57 条
  • [11] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [12] DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582
  • [13] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [14] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [15] Friedlander P, 1996, MOL CELL BIOL, V16, P4961
  • [16] GE H, 1994, J BIOL CHEM, V269, P17136
  • [17] DNA-BINDING PROPERTIES OF THE HMG DOMAIN OF THE LYMPHOID-SPECIFIC TRANSCRIPTIONAL REGULATOR LEF-1
    GIESE, K
    AMSTERDAM, A
    GROSSCHEDL, R
    [J]. GENES & DEVELOPMENT, 1991, 5 (12B) : 2567 - 2578
  • [18] Gottlieb MT, 1996, BIOCHIM BIOPHYS ACTA, V1287, P77
  • [19] HMG DOMAIN PROTEINS - ARCHITECTURAL ELEMENTS IN THE ASSEMBLY OF NUCLEOPROTEIN STRUCTURES
    GROSSCHEDL, R
    GIESE, K
    PAGEL, J
    [J]. TRENDS IN GENETICS, 1994, 10 (03) : 94 - 100
  • [20] WILD-TYPE P53 ADOPTS A MUTANT-LIKE CONFORMATION WHEN BOUND TO DNA
    HALAZONETIS, TD
    DAVIS, LJ
    KANDIL, AN
    [J]. EMBO JOURNAL, 1993, 12 (03) : 1021 - 1028